Your session is about to expire
← Back to Search
Photoimmunotherapy for Head and Neck Cancer
Study Summary
This trial is studying the side effects of a new cancer treatment and how well it works in patients with head and neck or skin cancer.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is ASP-1929 Photoimmunotherapy a safe and reliable treatment for individuals?
"With limited efficacy data, but some safety evidence already gathered, our team at Power rated ASP-1929 Photoimmunotherapy a 2 on the 1 to 3 scale."
What is the current participation level in this research endeavor?
"Affirmative. Clinicaltrials.gov contains evidence that this research, which commenced on January 21st 2022, is actively recruiting participants. 22 individuals are being sought to take part in the experiment at one particular site."
Is this experiment currently recruiting participants?
"As evidenced by clinicaltrials.gov, this medical study has opened up recruitment and is actively looking for volunteers. Its listing was initially posted on January 21st 2022 with the latest update occurring on May 23rd 2022."
Share this study with friends
Copy Link
Messenger